AI in Nuclear Medicine: Improvements in the Field
AI in Nuclear Medicine: Improvements in the Field
Implementing a Successful Barostim Program in the Clinic: Best Practices and Real World Experience
Implementing a Successful Barostim Program in the Clinic: Best Practices and Real World Experience
Beyond the Surface: The Impact of Psoriasis on Cardiovascular Health
Beyond the Surface: The Impact of Psoriasis on Cardiovascular Health
How Artificial Sweeteners Could Be Linked to Heart Disease
How Artificial Sweeteners Could Be Linked to Heart Disease
Effects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
Effects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
Targeting cardiac energetics with cardiac mitotrope in nonobstructive HCM
Targeting cardiac energetics with cardiac mitotrope in nonobstructive HCM
Beyond the Horizon: HELIOS Clinical Trials in ATTR Cardiomyopathy
Beyond the Horizon: HELIOS Clinical Trials in ATTR Cardiomyopathy
Long-term improvements in daily steps with gamification and financial incentives in patients at risk for CV events
Long-term improvements in daily steps with gamification and financial incentives in patients at risk for CV events
Promising results for self-expanding TAVR device in trial with mostly women
Promising results for self-expanding TAVR device in trial with mostly women
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Preventive PCI versus optimal medical therapy only for vulnerable plaques
Preventive PCI versus optimal medical therapy only for vulnerable plaques
Promising results for APOC3 ASO in familial chylomicronemia syndrome
Promising results for APOC3 ASO in familial chylomicronemia syndrome
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Self-assessment on statin eligibility without prescription using a web app
Self-assessment on statin eligibility without prescription using a web app
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia